Trial Profile
Safety and Efficacy of Gemcitabine Based Neoadjuvant Chemotherapy Followed by Chemoradiation in Locally Advanced Cervical Cancer Patients and Association With Human Equilibrative Nucleoside Transporter 1 (hENT1) Expression
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Dec 2014 New trial record